Financing, Equity Capital Markets

CRISPR Therapeutics AG

09/18
|
$200.0 Million
Piper Sandler served as bookrunner for CRISPR Therapeutics, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma